O

OrbiMed Portfolio holdings

AUM $4.89B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+87.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.98B
AUM Growth
-$187M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
122
New
Increased
Reduced
Closed

Top Buys

1
+$81.8M
2
+$51.6M
3
+$30.1M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$23.2M
5
JBIO
Jade Biosciences
JBIO
+$18.1M

Top Sells

1
+$97.6M
2
+$76.6M
3
+$56.9M
4
SWTX
SpringWorks Therapeutics
SWTX
+$41.9M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.5M

Sector Composition

1 Healthcare 99.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
– –
-197,500
102
– –
0
103
– –
-2,540,136
104
– –
-933,500
105
– –
-821,400
106
– –
-95,100
107
– –
-3,850,200
108
– –
-94,093
109
– –
-4,001,711
110
– –
-151,800
111
– –
-116,785
112
– –
-550,000
113
– –
-481,065
114
– –
-2,862,448
115
– –
0
116
– –
-225,884
117
– –
-73,114,592
118
– –
-298,301
119
– –
-112,500
120
– –
-250,000
121
– –
-950,200
1 2 3 4
5